ARTICLE | Management Tracks
Former CBER Director Marks joins Lilly
He takes the role of SVP for molecule discovery and head of infectious diseases at the pharma
October 7, 2025 5:52 PM UTC
Peter Marks has joined Eli Lilly as SVP for molecule discovery and head of infectious diseases, marking his return to industry after nearly a decade at FDA.
Market analysts applauded news of Marks’ new position, while Trump administration sources expressed consternation. ...